Literature DB >> 19238010

Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes.

Rafael Cubas1, Sheng Zhang, Sunkuk Kwon, Eva M Sevick-Muraca, Min Li, Changyi Chen, Qizhi Yao.   

Abstract

Virus-like particles (VLPs) have gained increasing interest for their use as vaccines due to their repetitive antigenic structure that is capable of efficiently activating the immune system. The efficacy of VLP immunization may lie in its ability to traffic into draining lymph nodes while activating antigen-presenting cells to initiate the orchestration of signals required for the development of a robust immune response. Currently, there is no comprehensive study showing the correlation of different VLP vaccination routes to immune outcome. In this study, we took an optical imaging approach to directly visualize the trafficking of simian-human immunodeficiency (SHIV) VLPs after immunization by commonly used routes and analyzed the corresponding humoral and cellular immune responses generated. We found that VLPs can easily enter the subcapsular sinus of draining lymph nodes with quantitative differences in the number of lymph node involvement depending on the immunization route used. Intradermal immunization led to the largest level of lymph node involvement for the longest period of time, which correlated with the strongest humoral and cellular immune responses. Flow cytometry analysis from extracted splenocytes showed that intradermal immunization led to the largest population of germinal center and activated B cells, which translated into higher antibody levels and antigen-specific cytotoxic T lymphocyte responses. Our results indicate that VLPs traffic into lymph nodes upon immunization and can be directly visualized by optical imaging techniques. Intradermal immunization showed improved responses and might be a preferable delivery route to use for viral and cancer immunotherapeutic studies involving VLPs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238010      PMCID: PMC2717166          DOI: 10.1097/CJI.0b013e31818f13c4

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  24 in total

Review 1.  Extrafollicular antibody responses.

Authors:  Ian C M MacLennan; Kai-Michael Toellner; Adam F Cunningham; Karine Serre; Daniel M-Y Sze; Elina Zúñiga; Matthew C Cook; Carola G Vinuesa
Journal:  Immunol Rev       Date:  2003-08       Impact factor: 12.988

2.  The reticulum of lymph nodes in mice studied with the electron microscope.

Authors:  S L CLARK
Journal:  Am J Anat       Date:  1962-05

3.  Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles.

Authors:  G T Layton; S J Harris; J Myhan; D West; F Gotch; M Hill-Perkins; J S Cole; N Meyers; S Woodrow; T J French; S E Adams; A J Kingsman
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

4.  SHIV virus-like particles bind and activate human dendritic cells.

Authors:  Rongxin Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Vaccine       Date:  2004-11-25       Impact factor: 3.641

5.  Visualization of specific B and T lymphocyte interactions in the lymph node.

Authors:  P Garside; E Ingulli; R R Merica; J G Johnson; R J Noelle; M K Jenkins
Journal:  Science       Date:  1998-07-03       Impact factor: 47.728

6.  The lymphatic vessels and the so-called "lymphatic stomata" of the diaphragm: a morphologic ultrastructural and three-dimensional study.

Authors:  G Azzali
Journal:  Microvasc Res       Date:  1999-01       Impact factor: 3.514

7.  FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen.

Authors:  K G Smith; G J Nossal; D M Tarlinton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 8.  The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells.

Authors:  J G Tew; R P Phipps; T E Mandel
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

9.  Ultrastructure and three-dimensional study of the lymphatic stomata in the costal pleura of the rabbit.

Authors:  Yan-Yuan Li; Ji-Cheng Li
Journal:  Microsc Res Tech       Date:  2003-10-15       Impact factor: 2.769

10.  Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection.

Authors:  R Wagner; V J Teeuwsen; L Deml; F Notka; A G Haaksma; S S Jhagjhoorsingh; H Niphuis; H Wolf; J L Heeney
Journal:  Virology       Date:  1998-05-25       Impact factor: 3.616

View more
  56 in total

1.  Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.

Authors:  Yuan Lu; Wei Chan; Benjamin Y Ko; Christopher C VanLang; James R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

Review 2.  Virus-based nanoparticles as platform technologies for modern vaccines.

Authors:  Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-19

3.  Comparison of Models for Bubonic Plague Reveals Unique Pathogen Adaptations to the Dermis.

Authors:  Rodrigo J Gonzalez; Eric H Weening; M Chelsea Lane; Virginia L Miller
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

Review 4.  Materials engineering for immunomodulation.

Authors:  Jeffrey A Hubbell; Susan N Thomas; Melody A Swartz
Journal:  Nature       Date:  2009-11-26       Impact factor: 49.962

5.  Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals.

Authors:  Jae-Keun Park; Dong-Hun Lee; Seong-Su Yuk; Erdene-Ochir Tseren-Ochir; Jung-Hoon Kwon; Jin-Yong Noh; Byoung-Yoon Kim; Soo-Won Choi; Sang-Moo Kang; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

6.  New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.

Authors:  Mario Amacker; Charli Smardon; Laura Mason; Jack Sorrell; Kirk Jeffery; Michael Adler; Farien Bhoelan; Olga Belova; Mark Spengler; Beena Punnamoottil; Markus Schwaller; Olivia Bonduelle; Behazine Combadière; Toon Stegmann; Andrew Naylor; Richard Johnson; Desmond Wong; Sylvain Fleury
Journal:  NPJ Vaccines       Date:  2020-05-18       Impact factor: 7.344

7.  Fluorescence imaging of the lymph node uptake of proteins in mice after subcutaneous injection: molecular weight dependence.

Authors:  Fang Wu; Suraj G Bhansali; Wing Cheung Law; Earl J Bergey; Paras N Prasad; Marilyn E Morris
Journal:  Pharm Res       Date:  2012-02-29       Impact factor: 4.200

Review 8.  Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy.

Authors:  Jardin Leleux; Alexandra Atalis; Krishnendu Roy
Journal:  J Control Release       Date:  2015-10-20       Impact factor: 9.776

9.  Fc microparticles can modulate the physical extent and magnitude of complement activity.

Authors:  Brandon Alexander Holt; Michael C Bellavia; Daniel Potter; David White; Sean R Stowell; Todd Sulchek
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

10.  Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.

Authors:  Jaina M Patel; Vincent F Vartabedian; Min-Chul Kim; Sara He; Sang-Moo Kang; Periasamy Selvaraj
Journal:  Biotechnol Bioeng       Date:  2015-04-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.